Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

Learn about the impact of Alzheimer's family history on brain resilience and memory function. Your family tree may shape your ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

A new blood test could revolutionize the diagnosis and treatment of Alzheimer's. Beyond confirming the presence of the disease, the test also helps determine the stage of its progression. FOX Medical ...

A smell test is less invasive and more accessible than other methods like PET scans, lumbar punctures or blood tests.

The promising test zeroes in on a biomarker in the blood, called phospho-tau217 (p-tau217). Scientists have discovered that ...

A study has looked into whether a simple test could help predict and intervene early against Alzheimer's disease and related ...

A simpler method of analyzing blood samples for Alzheimer's disease has been tested in a large multi-center study.